Literature DB >> 26860972

Protective Effect of Gomisin N against Endoplasmic Reticulum Stress-Induced Hepatic Steatosis.

Min-Kyung Jang1, Ye-Rang Yun, Seon Hoo Kim, Ji Ha Kim, Myeong Ho Jung.   

Abstract

Gomisin N is a physiological substance derived from Schisandra chinensis. In the present study, the in vitro and in vivo effects of gomisin N on endoplasmic reticulum (ER) stress and hepatic steatosis were investigated. We quantified the expression of markers of ER stress, including glucose regulated protein 78 (GRP78), CCAAT/enhancer binding protein (C/EBP) homolog protein (CHOP), and X-box-binding protein-1 (XBP-1), and triglyceride (TG) accumulation, in HepG2 cells treated with tunicamycin or palmitate. Tunicamycin treatment in HepG2 cells induced expression of markers of ER stress and increased TG levels; Gomisin N reversed these effects, reducing the expression of markers of ER stress and TG levels. Similar effects were seen following palmitate pretreatment of HepG2 cells. The inhibitory effects of gomisin N were further confirmed in mice injected with tunicamycin. Gomisin N reduced expression of markers of ER stress and decreased TG levels in mouse liver after tunicamycin injection. Furthermore, gomisin N decreased expression of inflammatory and lipogenic genes in palmitate-incubated HepG2 cells. These results suggest that gomisin N inhibits ER stress and ameliorates hepatic steatosis induced by ER stress.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26860972     DOI: 10.1248/bpb.b15-01020

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  7 in total

Review 1.  Schisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver Disease.

Authors:  Pou Kuan Leong; Kam Ming Ko
Journal:  Oxid Med Cell Longev       Date:  2016-10-26       Impact factor: 6.543

2.  Schisandrae Fructus Reduces Symptoms of 4-Vinylcyclohexene Diepoxide-Induced Ovarian Failure in Mice.

Authors:  Dasom Shin; Jinhee Ha; Seong Bin Hong; Geun-Hyung Kang; Deok-Sang Hwang; Hyunsu Bae
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-11       Impact factor: 2.629

3.  Gomisin N inhibits adipogenesis and prevents high-fat diet-induced obesity.

Authors:  Min-Kyung Jang; Ye-Rang Yun; Ji-Hyun Kim; Mi-Hee Park; Myeong Ho Jung
Journal:  Sci Rep       Date:  2017-01-09       Impact factor: 4.379

4.  Protective Effects of Gomisin N against Hepatic Cannabinoid Type 1 Receptor-Induced Insulin Resistance and Gluconeogenesis.

Authors:  Arulkumar Nagappan; Dae Young Jung; Ji-Hyun Kim; Myeong Ho Jung
Journal:  Int J Mol Sci       Date:  2018-03-23       Impact factor: 5.923

5.  Potential protective benefits of Schisandrin B against severe acute hepatitis in children during the COVID-19 pandemic based on a network pharmacology analysis.

Authors:  Yanhua Fang; Lingling Zhang; Zhe Wang; Ruoyu Wang; Shanshan Liang
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

6.  Gomisin N Alleviates Ethanol-Induced Liver Injury through Ameliorating Lipid Metabolism and Oxidative Stress.

Authors:  Arulkumar Nagappan; Dae Young Jung; Ji-Hyun Kim; Hoyoung Lee; Myeong Ho Jung
Journal:  Int J Mol Sci       Date:  2018-09-01       Impact factor: 5.923

7.  Role of X-Box Binding Protein-1 in Fructose-Induced De Novo Lipogenesis in HepG2 Cells.

Authors:  Xian Yu; Lu-Ping Ren; Chao Wang; Ya-Jun Zhu; Han-Ying Xing; Jing Zhao; Guang-Yao Song
Journal:  Chin Med J (Engl)       Date:  2018-10-05       Impact factor: 2.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.